Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2025-12-30 @ 3:10 AM
Study NCT ID:
NCT03213457
Status:
COMPLETED
Last Update Posted:
2024-12-20
First Post:
2017-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-06
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-07
First Submit QC Date:
None
Study First Post Date:
2017-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-03-24
Results First Submit QC Date:
None
Results First Post Date:
2021-04-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-25
Last Update Post Date:
2024-12-20
Last Update Post Date Type:
ACTUAL